Rimegepant Sulfate
Brand name: Nurtec Odt
Rank #113 of 500 drugs by total cost
$155.0M
Total Cost
106,692
Total Claims
$155.0M
Total Cost
3,508
Prescribers
$1,453
Cost per Claim
13,273
Beneficiaries
109,328
30-Day Fills
$44K
Avg Cost/Provider
30
Avg Claims/Provider
About Rimegepant Sulfate
Rimegepant Sulfate (sold as Nurtec Odt) was prescribed 106,692 times by 3,508 Medicare Part D providers in 2023, costing the program $155.0M. At $1,453 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 110 | Pantoprazole Sodium (Pantoprazole Sodium) | $165.1M | 10,061,854 |
| 111 | Lenvatinib Mesylate (Lenvima) | $164.6M | 7,004 |
| 112 | Treprostinil (Tyvaso Dpi) | $158.9M | 6,704 |
| 113 | Rimegepant Sulfate (Nurtec Odt) | $155.0M | 106,692 |
| 114 | Teriparatide (Forteo) | $153.9M | 38,259 |
| 115 | Ixekizumab (Taltz Autoinjector) | $149.8M | 19,972 |
| 116 | Sofosbuvir/Velpatasvir (Epclusa) | $149.4M | 6,544 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology